A previous study has shown that under hypoxia conditions, HK2, LDHA, and glucose transporter 1 (GLUT1) are upregulated in prostate cancer cells, and brusatol treatment inhibits glycolysis by decreasing the expression of these glycolysis-related enzymes [52]. This evidence concerns the gene SLC2A1 and prostate carcinoma.